Estrella Immunopharma Inc. (NASDAQ: ESLA)
$1.2500
+0.0788 ( +14.68% ) 17.0K
Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.
Market Data
Open
$1.2500
Previous close
$1.1712
Volume
17.0K
Market cap
$42.37M
Day range
$1.0600 - $1.2350
52 week range
$0.6300 - $3.2300
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Aug 20, 2024 |
8-k | 8K-related | 15 | Aug 06, 2024 |
8-k | 8K-related | 14 | Jul 02, 2024 |
10-q | Quarterly Reports | 68 | May 15, 2024 |
8-k | 8K-related | 15 | May 13, 2024 |
8-k | 8K-related | 44 | Apr 10, 2024 |
8-k | 8K-related | 15 | Mar 11, 2024 |
8-k | 8K-related | 16 | Mar 07, 2024 |
10-q | Quarterly Reports | 69 | Feb 14, 2024 |
8-k | 8K-related | 16 | Feb 02, 2024 |